Literature DB >> 28607577

MRI in the assessment and monitoring of multiple sclerosis: an update on best practice.

Ulrike W Kaunzner1, Susan A Gauthier2.   

Abstract

Magnetic resonance imaging (MRI) has developed into the most important tool for the diagnosis and monitoring of multiple sclerosis (MS). Its high sensitivity for the evaluation of inflammatory and neurodegenerative processes in the brain and spinal cord has made it the most commonly used technique for the evaluation of patients with MS. Moreover, MRI has become a powerful tool for treatment monitoring, safety assessment as well as for the prognostication of disease progression. Clinically, the use of MRI has increased in the past couple decades as a result of improved technology and increased availability that now extends well beyond academic centers. Consequently, there are numerous studies supporting the role of MRI in the management of patients with MS. The aim of this review is to summarize the latest insights into the utility of MRI in MS.

Entities:  

Keywords:  McDonald criteria; lesion; magnetic resonance imaging; multiple sclerosis; no evidence of disease activity; treatment efficacy

Year:  2017        PMID: 28607577      PMCID: PMC5453402          DOI: 10.1177/1756285617708911

Source DB:  PubMed          Journal:  Ther Adv Neurol Disord        ISSN: 1756-2856            Impact factor:   6.570


  144 in total

1.  Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis.

Authors:  Valentina Tomassini; Andrea Paolillo; Pierluigi Russo; Elisabetta Giugni; Luca Prosperini; Claudio Gasperini; Guido Antonelli; Stefano Bastianello; Carlo Pozzilli
Journal:  J Neurol       Date:  2005-09-14       Impact factor: 4.849

2.  Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.

Authors:  Sarah C Reitz; Stephanie-Michelle Hof; Vinzenz Fleischer; Alla Brodski; Adriane Gröger; René-Maxime Gracien; Amgad Droby; Helmuth Steinmetz; Ulf Ziemann; Frauke Zipp; Ralf Deichmann; Johannes C Klein
Journal:  Brain Imaging Behav       Date:  2017-06       Impact factor: 3.978

3.  Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy.

Authors:  Tomonori Kanda; Toshio Fukusato; Megumi Matsuda; Keiko Toyoda; Hiroshi Oba; Jun'ichi Kotoku; Takahiro Haruyama; Kazuhiro Kitajima; Shigeru Furui
Journal:  Radiology       Date:  2015-05-05       Impact factor: 11.105

4.  Defining interferon beta response status in multiple sclerosis patients.

Authors:  Richard A Rudick; Jar-Chi Lee; Jack Simon; Richard M Ransohoff; Elizabeth Fisher
Journal:  Ann Neurol       Date:  2004-10       Impact factor: 10.422

5.  Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis.

Authors:  James M Stankiewicz; Bonnie I Glanz; Brian C Healy; Ashish Arora; Mohit Neema; Ralph H B Benedict; Zachary D Guss; Shahamat Tauhid; Guy J Buckle; Maria K Houtchens; Samia J Khoury; Howard L Weiner; Charles R G Guttmann; Rohit Bakshi
Journal:  J Neuroimaging       Date:  2011-04       Impact factor: 2.486

6.  Predictors of long-term outcome in multiple sclerosis patients treated with interferon β.

Authors:  Robert A Bermel; Xiaojun You; Pamela Foulds; Robert Hyde; Jack H Simon; Elizabeth Fisher; Richard A Rudick
Journal:  Ann Neurol       Date:  2013-01       Impact factor: 10.422

7.  2010 McDonald criteria for diagnosing pediatric multiple sclerosis.

Authors:  Yair Sadaka; Leonard H Verhey; Manohar M Shroff; Helen M Branson; Douglas L Arnold; Sridar Narayanan; John G Sled; Amit Bar-Or; A Dessa Sadovnick; Melissa McGowan; Ruth Ann Marrie; Brenda Banwell
Journal:  Ann Neurol       Date:  2012-08       Impact factor: 10.422

8.  Profilometry: A new statistical framework for the characterization of white matter pathways, with application to multiple sclerosis.

Authors:  Michael Dayan; Elizabeth Monohan; Sneha Pandya; Amy Kuceyeski; Thanh D Nguyen; Ashish Raj; Susan A Gauthier
Journal:  Hum Brain Mapp       Date:  2015-12-15       Impact factor: 5.038

9.  Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome.

Authors:  Gijsbert J A Nagtegaal; Christoph Pohl; Mike P Wattjes; Hanneke E Hulst; Mark S Freedman; Hans-Peter Hartung; David Miller; Xavier Montalban; Ludwig Kappos; Gilles Edan; Dirk Pleimes; Karola Beckman; Brigitte Stemper; Christoph H Polman; Rupert Sandbrink; Frederik Barkhof
Journal:  Mult Scler       Date:  2013-07-10       Impact factor: 6.312

Review 10.  Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group.

Authors:  C McGuigan; M Craner; J Guadagno; R Kapoor; G Mazibrada; P Molyneux; R Nicholas; J Palace; O R Pearson; D Rog; C A Young
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-10-22       Impact factor: 10.154

View more
  25 in total

1.  Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.

Authors:  Dominique Eden; Charley Gros; Atef Badji; Sara M Dupont; Benjamin De Leener; Josefina Maranzano; Ren Zhuoquiong; Yaou Liu; Tobias Granberg; Russell Ouellette; Leszek Stawiarz; Jan Hillert; Jason Talbott; Elise Bannier; Anne Kerbrat; Gilles Edan; Pierre Labauge; Virginie Callot; Jean Pelletier; Bertrand Audoin; Henitsoa Rasoanandrianina; Jean-Christophe Brisset; Paola Valsasina; Maria A Rocca; Massimo Filippi; Rohit Bakshi; Shahamat Tauhid; Ferran Prados; Marios Yiannakas; Hugh Kearney; Olga Ciccarelli; Seth A Smith; Constantina Andrada Treaba; Caterina Mainero; Jennifer Lefeuvre; Daniel S Reich; Govind Nair; Timothy M Shepherd; Erik Charlson; Yasuhiko Tachibana; Masaaki Hori; Kouhei Kamiya; Lydia Chougar; Sridar Narayanan; Julien Cohen-Adad
Journal:  Brain       Date:  2019-03-01       Impact factor: 13.501

Review 2.  Genotype and Phenotype in Multiple Sclerosis-Potential for Disease Course Prediction?

Authors:  Vilija G Jokubaitis; Yuan Zhou; Helmut Butzkueven; Bruce V Taylor
Journal:  Curr Treat Options Neurol       Date:  2018-04-24       Impact factor: 3.598

Review 3.  Multiple Sclerosis: Systemic Challenges to Cost-Effective Care.

Authors:  David R Weinstein; Gary M Owens; Ankit Gandhi
Journal:  Am Health Drug Benefits       Date:  2022-03

Review 4.  Imaging in Pediatric Multiple Sclerosis : An Iconographic Review.

Authors:  Gonzalo Barraza; Kumaran Deiva; Béatrice Husson; Catherine Adamsbaum
Journal:  Clin Neuroradiol       Date:  2020-07-16       Impact factor: 3.649

5.  7 T Magnetic Resonance Spectroscopic Imaging in Multiple Sclerosis: How Does Spatial Resolution Affect the Detectability of Metabolic Changes in Brain Lesions?

Authors:  Eva Heckova; Bernhard Strasser; Gilbert J Hangel; Michal Považan; Assunta Dal-Bianco; Paulus S Rommer; Petr Bednarik; Stephan Gruber; Fritz Leutmezer; Hans Lassmann; Siegfried Trattnig; Wolfgang Bogner
Journal:  Invest Radiol       Date:  2019-04       Impact factor: 6.016

6.  Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study.

Authors:  Douglas L Arnold; Brenda Banwell; Amit Bar-Or; Angelo Ghezzi; Benjamin M Greenberg; Emmanuelle Waubant; Gavin Giovannoni; Jerry S Wolinsky; Jutta Gärtner; Kevin Rostásy; Lauren Krupp; Marc Tardieu; Wolfgang Brück; Tracy E Stites; Gregory L Pearce; Dieter A Häring; Martin Merschhemke; Tanuja Chitnis
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-03-04       Impact factor: 10.154

7.  Activated monocytes and markers of inflammation in newly diagnosed multiple sclerosis.

Authors:  Mikkel Carstensen; Tove Christensen; Morten Stilund; Holger J Møller; Eva L Petersen; Thor Petersen
Journal:  Immunol Cell Biol       Date:  2020-05-05       Impact factor: 5.126

Review 8.  Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia.

Authors:  Candice E Crocker; Philip G Tibbo
Journal:  Front Pharmacol       Date:  2018-10-18       Impact factor: 5.810

9.  Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis.

Authors:  Vinzenz Fleischer; Nabin Koirala; Amgad Droby; René-Maxime Gracien; Ralf Deichmann; Ulf Ziemann; Sven G Meuth; Muthuraman Muthuraman; Frauke Zipp; Sergiu Groppa
Journal:  Ther Adv Neurol Disord       Date:  2019-04-24       Impact factor: 6.570

Review 10.  Role of Vitamin D in Preventing and Treating Selected Extraskeletal Diseases-An Umbrella Review.

Authors:  Friederike Maretzke; Angela Bechthold; Sarah Egert; Jana B Ernst; Debora Melo van Lent; Stefan Pilz; Jörg Reichrath; Gabriele I Stangl; Peter Stehle; Dorothee Volkert; Michael Wagner; Julia Waizenegger; Armin Zittermann; Jakob Linseisen
Journal:  Nutrients       Date:  2020-03-31       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.